Invasive aspergillosis;La aspergilosis invasora

Revista Iberoamericana de Micologia

Volumn 20, Issue 3, 2003, Pages 77-78

  Del Palacio, Amalia ^a   Soledad Cuétara, María ^b   Pontón, José ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Aspergillus; Diagnosis; Invasive aspergillosis; Platelia Aspergillus

Indexed keywords

GALACTOMANNAN;

ASPERGILLOSIS; ASPERGILLUS; CANCER PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK POPULATION; HUMAN; LABORATORY DIAGNOSIS; MORTALITY; MYCOSIS; NEUTROPENIA; REVIEW; SPAIN;

ASPERGILLOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; MANNANS; NEUTROPENIA;

ASPERGILLUS;

EID: 0345871005     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Pontón J, Cabañes FJ. Aspergillus y aspergilosis nosocomial. Rev Iberoam Micol 2000; 17: S77-S78.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
3. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33: 1824-1833.
4. Ascioglu S, de Paw B, Bennett JE, et al. Analysis of the definitions used in clinical research on invasive fungal infections: consensus proposal for new standardized definitions. Clin Infect Dis 2002; 34: 7-14.
5. Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk based, antifungal strategy in neutropenic patients. Br J Haematol 2000; 110: 273-284.
6. Stevens DA. Diagnosis of fungal infections: current status. J Clin Microbiol 2002; 49: S11-S19.
7. Singh N. Antifungal prophylaxis for solid organ transplant recipients: Seeking clarity amidst controversity. Clin Infect Dis 2000; 31: 545-553.
8. Pinel C, Fricker-Hidalgo H, Lebeau B, et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003; 41: 2184-2186.
9. Sulahian A, Tabouret M, Ribaud P, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive candidiasis. Eur J Clin Microbiol 1996; 15: 139-145.
10. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of the invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-1906.
11. Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a noninvasive diagnosis tool for invasive aspergilosis in prolonged neutropenic patients and stem cell transplantation recipients. A prospective validation. Blood 2001; 97: 1604-1610.
12. Costa C, Costa JM, Desterke C, et al. Real time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2002; 40: 2224-2227.